- Publisher's listprice EUR 160.49
-
68 079 Ft (64 837 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 13 616 Ft off)
- Discounted price 54 463 Ft (51 870 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
68 079 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 2nd ed. 2007
- Publisher Humana
- Date of Publication 27 July 2007
- Number of Volumes 1 pieces, Book
- ISBN 9781588296962
- Binding Hardback
- No. of pages508 pages
- Size 254x178 mm
- Weight 1205 g
- Language English
- Illustrations XXI, 508 p. Tables, black & white 0
Categories
Long description:
Prostate Cancer: Biology, Genetics, and the New Therapeutics, Second Edition, reviews new, valuable approaches to the treatment of prostate cancer in men. The latest edition contains new material on molecular imaging, new treatments for prostate cancer, molecular targets, cell signaling pathways, bioinformatics, and pathogenomics. The book details the latest innovations and advances in prostate cancer and may be used as a rapid reference text for readers.
The volume profiles the latest advances in cancer research and treatment and includes profound studies in prostate stem cells, cancer-host interactions, hedgehog signaling in development and cancer, cholesterol and cell signaling, gene therapy for advanced prostate cancer, and noninvasive strategies such as molecular imaging to visualize gene expression. This new edition also investigates expression profiling and somatic alterations in prostate cancer progression and linkage studies of prostate cancer families to identify susceptibility genes. The issues of racial differences in prostate cancer mortality, radiotherapy for the treatment of locally advanced prostate cancer, recombinant antibody candidates for treatment, taxane-based chemotherapy, lethal phenotypes, and novel and efficient translation clinical trials are also presented in great depth.
Prostate Cancer: Biology, Genetics, and the New Therapeutics, Second Edition, provides readers with a general reference for prostate cancer from prevention to therapy and will be of value to clinicians, scientists, and administrators who strive to solve the cancer problem.
From the reviews of the second edition:
"This book relates the latest knowledge and technology in translational research in prostate cancer. It is a valuable reference and guide for any one working in translational prostate cancer research ? and it is easy to read. This is a must read for those who are about to enter the field of translational research in prostate cancer, but it also serves as an excellent reference for established investigators." (Chung Lee, Doody?s Review Service, July, 2008)
"Seventy-five contributors produced this excellent textbook (Chung, et.al) which offers an overview in the wide field of prostate cancer. ? Researchers will find in this textbook comprehensive information and clinicians will obtain an excellent overview of the utility of research that has bearing on the future of their practise." (European Urology Today, August, 2008)
"The book contains three parts from which part one covers ?Biology and Imaging?. Part II deals with ?Genetics? and part III covers?Therapeutics?. ? It can be a good guide for any person interested in research and daily treatment of prostate cancer because it covers a wide range of interesting topics and it stimulates the reader to further elaborate certain topics of prostate cancer." (Sylvie Rottey, Acta Clinica Belgica, Vol. 63 (3), 2008)
MoreTable of Contents:
Biology and Imaging.- Xenograft Models of Human Prostate Cancer.- The Pathology of Human Prostatic Atrophy and Inflammation.- Tissue Microarrays in Prostate Cancer Research.- Prostate (Cancer) Stem Cells.- Cancer-Host Interactions.- Androgen Receptor Function in Prostate Cancer Progression.- Hedgehog Signaling in Development and Cancer.- Cholesterol, Cell Signaling, and Prostate Cancer.- Gene Therapy for Advanced Prostate Cancer.- Role of Transforming Growth Factor-? in Immunotherapy of Prostate Cancer.- Biology and Therapeutic Basis of Prostate Cancer Bone Metastasis.- Molecular Imaging.- Quantum Dot Nanotechnology for Prostate Cancer Research.- Genetics.- Expression Profiling of Prostate Cancer Progression.- Somatic Alterations in Prostate Cancer Progression.- Linkage Studies of Prostate Cancer Families to Identify Susceptibility Genes.- Somatic DNA Methylation Changes and Prostatic Carcinogenesis.- Telomeres, Telomerase, Chromosome Stability, and Prostate Cancer.- Therapeutics.- Racial Differences in Prostate Cancer Mortality.- Radiotherapy for the Treatment of Locally Advanced Prostate Cancer.- Recombinant Antibody Candidates for Treatment of Prostate Cancer.- Differentiation Agents and Epigenomic Therapies.- Taxane-Based Chemotherapy for Prostate Cancer.- Co-Targeting Therapeutics for Hormone Refractory Prostate Cancer.- Intercellular Targets of Prostate Cancer.- Novel and Efficient Translational Clinical Trial Designs in Advanced Prostate Cancer.
More
